Related Experiment Videos
[Motor neuron diseases: a type of programmed cell death?]
1Unidad de Neuropatología, Hospital Príncipes de España, Universidad de Barcelona, L'Hospitalet de Llobregat.
Neurologia (Barcelona, Spain)
|December 1, 1996
Summary
Motor neuron diseases like ALS and SMA involve motor neuron loss and distinct cellular changes. These pathological features differ from normal programmed cell death, suggesting unique disease mechanisms.
Area of Science:
- Neurology
- Cell Biology
- Pathology
Context:
- Motor neuron diseases (MNDs), including amyotrophic lateral sclerosis (ALS) and spinal muscular atrophies (SMAs), are debilitating neurological conditions.
- These diseases are characterized by the progressive loss of motor neurons in the spinal cord's anterior horn.
Purpose:
- To investigate the pathological hallmarks of motor neuron diseases, focusing on cellular morphology and cell death mechanisms.
- To differentiate the cell death pathways in MNDs from naturally occurring programmed cell death.
Summary:
- Motor neuron diseases exhibit motor neuron loss, chromatolysis, and the accumulation of phosphorylated neurofilaments and ubiquitinated inclusions.
- Axonal balloonings are observed in ALS, while both ALS and SMAs show chromatolytic cells filled with phosphorylated neurofilaments.
- Loss of synaptic afferents occurs in chromatolytic cells, indicating a later stage of the disease process.
- Distinctive morphological features, including the absence of c-Jun/AP-1 and DNA fragmentation staining, differentiate MND pathology from programmed cell death.
- While gene deletions (SMN, NAIP) are linked to SMA, its cell death program is not simply a reactivation of developmental processes.
Impact:
- Provides insights into the unique pathological mechanisms underlying motor neuron diseases.
- Helps distinguish MNDs from other neurological disorders based on cellular pathology.
- Contributes to understanding the complex cell death pathways involved in neurodegeneration.